This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Isofol Medical Ab. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Göteborg, SE (2019)
- Gothenburg, SE (2021)
Company Filing History:
Years Active: 2019-2026
Title: Innovations by Per L Lindberg in Cancer Treatment
Introduction
Per L Lindberg is a noted inventor based in Gothenburg, Sweden, who has made significant contributions to cancer treatment. With two patents to his name, his work primarily focuses on enhancing chemotherapy effectiveness, specifically targeting colorectal cancer.
Latest Patents
Lindberg's recent innovations include two patents centered around the use of [6R]-5,10-methylenetetrahydrofolate (MTHF) as an adjuvant in chemotherapy. The first patent, titled "[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy," describes a method for administering this diastereomerically pure folate adjuvant within 5-fluorouracil (5-FU) based treatment regimens for solid tumors, including colorectal cancer (CRC). The second patent, "[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy," outlines a protocol for administering multiple boluses of [6R]-MTHF to improve treatment outcomes.
Career Highlights
Per L Lindberg works with Isofol Medical AB, a company dedicated to pioneering advances in oncology. His role has been pivotal in developing innovative treatment options that enhance the efficacy of existing chemotherapy therapies. Throughout his career, Lindberg has focused on research that bridges pharmacy and medical treatments, particularly in oncology.
Collaborations
Lindberg has collaborated with notable professionals in his field, including Anders Vedin and Gunnel E Sundén. These collaborations highlight the importance of teamwork in advancing medical innovations and ensuring the successful realization of complex patents.
Conclusion
Per L Lindberg stands out as a significant inventor within the realm of cancer research and treatment. His innovative patents focusing on the use of [6R]-MTHF in chemotherapy mark essential advancements in the fight against colorectal cancer, showcasing the potential of improved therapeutics in oncology. As cancer treatment continues to evolve, the contributions of innovators like Lindberg are vital for establishing more effective and targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile